Inside Moderna Therapeutics, biotech's most secretive startup
archive.today webpage capture Saved from history←priornext→ 6 Jan 2024 13:19:08 UTC Redirected from no other snapshots from this url All snapshots from host t.co from host www.statnews.com WebpageScreenshot sharedownload .zipreport bug or abuseBuy me a coffee Skip to Main Content Reporting from the frontiers of health and medicine Newsletters Log In Subscribe Biotech Pharma Public Health Health Tech Policy Science First Opinion STAT@JPM SPECIAL REPORT Ego, ambition, and turmoil: Inside one of biotech’s most secretive startups By Damian Garde Sept. 13, 2016 Reprints Stéphane Bancel spent most of his career in sales and operations before becoming CEO of biotech startup Moderna Therapeutics. ARAM BOGHOSIAN FOR STAT C AMBRIDGE, Mass. — At first glance, Moderna Therapeutics looks like the most enviable biotech startup in the world. It has smashed fundraising records and teamed up with pharmaceutical giants as it pursues a radical plan to revolutionize medicine by transfo